Riv Capital Stock Revenue
| CNPOF Stock | USD 0.08 0 4.88% |
RIV Capital fundamentals help investors to digest information that contributes to RIV Capital's financial success or failures. It also enables traders to predict the movement of RIV Pink Sheet. The fundamental analysis module provides a way to measure RIV Capital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RIV Capital pink sheet.
RIV |
RIV Capital Company Revenue Analysis
RIV Capital's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current RIV Capital Revenue | 1.78 M |
Most of RIV Capital's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RIV Capital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, RIV Capital reported 1.78 M of revenue. This is 99.98% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 99.98% higher than that of the company.
RIV Capital is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 3.56 Million. RIV Capital totals roughly 1.78 Million in revenue claiming about 50% of equities under Drug Manufacturers—Specialty & Generic industry.RIV Fundamentals
| Return On Equity | -0.74 | |||
| Return On Asset | -0.0219 | |||
| Operating Margin | (2.72) % | |||
| Current Valuation | (21.3 M) | |||
| Shares Outstanding | 169.13 M | |||
| Shares Owned By Insiders | 19.10 % | |||
| Shares Owned By Institutions | 30.88 % | |||
| Price To Earning | 7.27 X | |||
| Price To Book | 0.23 X | |||
| Price To Sales | 7.93 X | |||
| Revenue | 1.78 M | |||
| Gross Profit | 1.9 M | |||
| EBITDA | (57.77 M) | |||
| Net Income | (52.73 M) | |||
| Cash And Equivalents | 171.54 M | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 100.45 M | |||
| Debt To Equity | 0.36 % | |||
| Current Ratio | 4.32 X | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (28.39 M) | |||
| Earnings Per Share | (0.28) X | |||
| Beta | 1.51 | |||
| Market Capitalization | 21.5 M | |||
| Total Asset | 457.62 M | |||
| Net Asset | 457.62 M |
About RIV Capital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RIV Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RIV Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RIV Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in RIV Pink Sheet
RIV Capital financial ratios help investors to determine whether RIV Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RIV with respect to the benefits of owning RIV Capital security.